Atlas Trials

Advanced Lung Non-Small Cell Carcinoma

28 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Lung Non-Small Cell Carcinoma

RecordFirmDate
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors (NCT05334329)University of California, Irvine2022-07-20
Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial (NCT05339022)Ohio State University Comprehensive Cancer Center2022-04-14
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT05096663)SWOG Cancer Research Network2022-03-15
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer (NCT05166616)City of Hope Medical Center2022-03-07
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC (NCT05198154)Fang Wu2022-01-24
A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy (NCT04856176)Tufts Medical Center2022-01-03
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484)National Cancer Institute (NCI)2021-11-22
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942)National Cancer Institute (NCI)2021-08-25
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040)M.D. Anderson Cancer Center2021-04-14
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC (NCT04754815)Shirish Gadgeel2021-04-01
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer (NCT04762199)Emory University2021-02-24
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer (NCT04396535)Mayo Clinic2020-10-23
Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer (NCT03831932)National Cancer Institute (NCI)2020-03-16
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy (NCT04186988)University of California, Davis2019-11-05
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change (NCT03191149)National Cancer Institute (NCI)2018-04-25

Track Advanced Lung Non-Small Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.